Hims & Hers abandons copycat weight-loss drug in face of FDA probe – Financial Times
- Hims & Hers abandons copycat weight-loss drug in face of FDA probe Financial Times
- Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill The New York Times
- Hims to stop offering GLP-1 pill after FDA warned of crackdown Reuters
- Hims & Hers will stop selling compounded version of Novo’s obesity pill statnews.com
- U.S. signals crackdown on compounded weight-loss drugs; Hims shares tumble CNBC
First Appeared on
Source link
